Brief: PCI Biotech and Etherna Immunotherapies start research collaboration
Dec 8 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* PCI Biotech and Etherna Immunotherapies initiate research collaboration
* Collaborators will evaluate technology compatibility and synergy based on in vivo studies
Source text for Eikon: ID:nGNErVK96
Further company coverage: PCIB.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process